Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Hoping Drugs Take Root, Alder Raises $38 Million Round

Apr 19 2012

• By Paul Bonanos

Related Content

Merck Gets A Headache: Unexpectedly Halts Development Of Migraine Drug

Sep 10 2009

Bristol Pays $85 Million Upfront To Acquire Rheumatoid Arthritis Compound From Alder

Nov 10 2009

Alder Obtains First Milestone Under BMS Deal, Advances Own Program In Cancer Supportive Care

Jun 21 2011

Novo Ventures' Hot Streak Of Exits

Nov 01 2010

Biologics Swing For The Fences: Payer Perspectives On Antibodies In Primary Care

Mar 12 2012

Related Companies

Alder Biopharmaceuticals, Inc.

Bristol Myers Squibb Company

Merck & Co., Inc.

Additional Topics

United States Business Strategies Deals Clinical Trials BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window